GB3-15653-98219 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-21
Dose 1 — Pfizer-BioNTech
2022-06-28
Registered in v-safe
2022-06-28
Health check-in — day 7, dose 1, under 3
Feeling: Fair · Fever · Sleepiness, Irritability/crying

Under 3 check-in
2022-07-05
Health check-in — day 14, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-21
Health check-in — day 28, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-26
Dose 2 — Pfizer-BioNTech
2022-07-26
Health check-in — day 0, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-07-29
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-08-01
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-08-11
Health check-in — day 14, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-16
Health check-in — day 21, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-23
Health check-in — day 28, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-09-01
Health check-in — day 35, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-09-06
Health check-in — day 42, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-09-20
Dose 3 — Pfizer-BioNTech
2022-10-21
Health check-in — day 28, dose 3, under 3
Feeling: Good

Under 3 check-in
2022-10-25
Health check-in — day 35, dose 3, under 3
Feeling: Good

Under 3 check-in
2022-11-01
Survey response — day 42, dose 3, under 3
MedDRA: Nasal congestion — Feeling: Fair

Free text: Nasal congestion

MedDRA releases: 2024-11 · check-in free text available
2022-12-20
Health check-in — 3 months, dose 3, under 3
Feeling: Good

Under 3 check-in
2023-03-24
Survey response — 6 months, dose 3, under 3
MedDRA: COVID-19, Fatigue, Pyrexia, Respiratory tract congestion, Vomiting — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

MedDRA releases: 2024-11

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-06-21	Pfizer-BioNTech	No
2	2022-07-26	Pfizer-BioNTech	No
3	2022-09-20	Pfizer-BioNTech	No

Free text

Release 12 (Under 3) — day 42, dose 3, under 3

2022-11-01

Symptoms: Nasal congestion

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	Fatigue	·	·	✓
SD	Nasal congestion	·	·	✓
SD	Pyrexia	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SD	Vomiting	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release